140 related articles for article (PubMed ID: 12205256)
1. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.
van Wassenaer AG; Briët JM; van Baar A; Smit BJ; Tamminga P; de Vijlder JJ; Kok JH
Pediatrics; 2002 Sep; 110(3):534-9. PubMed ID: 12205256
[TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function in very preterm newborns: possible implications.
Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng SM; Turner MA; Weindling AM
Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
[No Abstract] [Full Text] [Related]
5. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome.
Biswas S; Buffery J; Enoch H; Bland JM; Walters D; Markiewicz M
Pediatrics; 2002 Feb; 109(2):222-7. PubMed ID: 11826199
[TBL] [Abstract][Full Text] [Related]
7. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
8. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
[TBL] [Abstract][Full Text] [Related]
9. Thyroid function in the preterm infant.
LaFranchi S
Thyroid; 1999 Jan; 9(1):71-8. PubMed ID: 10037080
[TBL] [Abstract][Full Text] [Related]
10. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy.
Pop VJ; Kuijpens JL; van Baar AL; Verkerk G; van Son MM; de Vijlder JJ; Vulsma T; Wiersinga WM; Drexhage HA; Vader HL
Clin Endocrinol (Oxf); 1999 Feb; 50(2):149-55. PubMed ID: 10396355
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function in very preterm infants: influences of gestational age and disease.
van Wassenaer AG; Kok JH; Dekker FW; de Vijlder JJ
Pediatr Res; 1997 Nov; 42(5):604-9. PubMed ID: 9357931
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopment of preterm infants born at 28 to 36 weeks of gestational age: the role of hypothyroxinemia and long-term outcome at 4 years.
Ares S; Quero J; Diez J; Morreale de Escobar G
J Pediatr Endocrinol Metab; 2011; 24(11-12):897-902. PubMed ID: 22308839
[TBL] [Abstract][Full Text] [Related]
13. Developmental follow-up of very low birthweight premature infants with low free thyroxine.
Karna P
Am J Perinatol; 1991 Jul; 8(4):288-91. PubMed ID: 1741876
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of thyroxine and free thyroxine filter paper measurements in neonatal screening for congenital hypothyroidism of preterm babies.
Gruñeiro-Papendieck L; Prieto L; Chiesa A; Bengolea S; Bossi G; Bergadá C
J Med Screen; 2000; 7(2):78-81. PubMed ID: 11002447
[TBL] [Abstract][Full Text] [Related]
15. Serum free T4 and thyroid stimulating hormone levels in preterm infants and relationship between these levels and respiratory distress syndrome.
Tanaka K; Shimizu T; Hosaka A; Tokita A; Shiga S; Yamashiro Y
Pediatr Int; 2007 Aug; 49(4):447-51. PubMed ID: 17587266
[TBL] [Abstract][Full Text] [Related]
16. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.
Reuss ML; Paneth N; Pinto-Martin JA; Lorenz JM; Susser M
N Engl J Med; 1996 Mar; 334(13):821-7. PubMed ID: 8596548
[TBL] [Abstract][Full Text] [Related]
17. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
18. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study.
Pop VJ; Brouwers EP; Vader HL; Vulsma T; van Baar AL; de Vijlder JJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):282-8. PubMed ID: 12919150
[TBL] [Abstract][Full Text] [Related]
19. General Movement assessment and neurodevelopmental trajectory in extremely preterm infants with hypothyroxinaemia of prematurity (THOP).
Goel D; Luig M; Maheshwari R; D'Cruz D; Goyen TA
Early Hum Dev; 2020 May; 144():104886. PubMed ID: 31668678
[TBL] [Abstract][Full Text] [Related]
20. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Manning D; Settle P; Gupta R; Newland P; Weindling AM
Trials; 2013 Jul; 14():211. PubMed ID: 23841945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
